Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized study

Transplant Proc. 1996 Dec;28(6):3204.

Authors

J M Langrehr¹, O Guckelberger, N Nüssler, A Radtke, H P Lemmens, S Jonas, R Lohmann, S Tullius, T Steinmüller, R Raakow, U Neumann, M Knoop, W O Bechstein, P Neuhaus

Affiliation

¹ Department of Surgery, Virchow Clinic, Humboldt University Berlin, Germany.

PMID: 8962241

No abstract available

Publication types

Clinical Trial
Comparative Study
Randomized Controlled Trial

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antilymphocyte Serum / therapeutic use*
Azathioprine / therapeutic use
Cyclosporine / therapeutic use
Drug Therapy, Combination
Humans
Immunosuppression Therapy / methods*
Immunosuppressive Agents / therapeutic use*
Liver Transplantation / immunology*
Prednisolone / therapeutic use
Receptors, Interleukin-2 / immunology*

Substances

Antibodies, Monoclonal
Antilymphocyte Serum
Immunosuppressive Agents
Receptors, Interleukin-2
Cyclosporine
Prednisolone
inolimomab
Azathioprine